A comparison of alteration frequencies between RPS6KB2 and RPS6KB1 in the TCGA pan-cancer dataset showed similar patterns, with amplification being the most common alteration across cancers, such as breast, endometrial, esophagogastric, ovarian, and bladder cancers. Here, RPS6KB2 is linked to cancer.